Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281747
Max Phase: Preclinical
Molecular Formula: C34H45N7O6
Molecular Weight: 647.78
Associated Items:
ID: ALA5281747
Max Phase: Preclinical
Molecular Formula: C34H45N7O6
Molecular Weight: 647.78
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@]1(C)Cc2c([nH]c3ccccc23)CN([C@@H](CCCCN)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C1=O
Standard InChI: InChI=1S/C34H45N7O6/c1-20(42)29(30(36)44)39-32(46)28(15-9-10-16-35)41-19-27-24(23-13-7-8-14-25(23)38-27)18-34(3,33(41)47)40-31(45)26(37-21(2)43)17-22-11-5-4-6-12-22/h4-8,11-14,20,26,28-29,38,42H,9-10,15-19,35H2,1-3H3,(H2,36,44)(H,37,43)(H,39,46)(H,40,45)/t20-,26+,28+,29+,34-/m1/s1
Standard InChI Key: TVDHJWHHMJAOCK-QOSLDAFVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 647.78 | Molecular Weight (Monoisotopic): 647.3431 | AlogP: 0.52 | #Rotatable Bonds: 14 |
Polar Surface Area: 212.74 | Molecular Species: BASE | HBA: 7 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.79 | CX Basic pKa: 25.01 | CX LogP: -0.31 | CX LogD: -2.80 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.12 | Np Likeness Score: 0.10 |
1. Van der Poorten O, Knuhtsen A, Sejer Pedersen D, Ballet S, Tourwé D.. (2016) Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design., 59 (24): [PMID:27690430] [10.1021/acs.jmedchem.6b01029] |
Source(1):